KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Net Income: 2010-2025

Historic Net Income for Opko Health (OPK) over the last 16 years, with Sep 2025 value amounting to $21.6 million.

  • Opko Health's Net Income fell 13.09% to $21.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$180.4 million, marking a year-over-year decrease of 34.89%. This contributed to the annual value of -$53.2 million for FY2024, which is 71.81% up from last year.
  • As of Q3 2025, Opko Health's Net Income stood at $21.6 million, which was up 114.57% from -$148.4 million recorded in Q2 2025.
  • Opko Health's Net Income's 5-year high stood at $31.1 million during Q1 2021, with a 5-year trough of -$148.4 million in Q2 2025.
  • Moreover, its 3-year median value for Net Income was -$19.6 million (2023), whereas its average is -$39.7 million.
  • Its Net Income has fluctuated over the past 5 years, first soared by 152.75% in 2021, then plummeted by 1,340.62% in 2025.
  • Quarterly analysis of 5 years shows Opko Health's Net Income stood at -$73.3 million in 2021, then declined by 16.23% to -$85.2 million in 2022, then climbed by 21.98% to -$66.5 million in 2023, then soared by 121.12% to $14.0 million in 2024, then decreased by 13.09% to $21.6 million in 2025.
  • Its last three reported values are $21.6 million in Q3 2025, -$148.4 million for Q2 2025, and -$67.6 million during Q1 2025.